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Accepted 25 September 2013Sister Mary Joseph's nodule was ﬁrst reported byWilliam James
Mayo's head surgical nurse, Sister Mary Joseph [1]. In 1949, this
term came into common use after Hamilton Bailey used it in
“Physical Signs in Clinical Surgery” [2]. Sister Mary Joseph's nodule
is a metastatic lesion of the umbilicus arising from intra-abdominal
or pelvic malignant disease [1,2]. Umbilical metastasis from intra-
abdominal cancer occurs primarily through lymphatic drainage
into the para-aortic lymph nodes. However, metastasis can also
spread through direct extension, venous routes, and embryonic
remnants [3]. In this paper, we report a patient who presented with
a uterine tumor and an umbilical nodule that mimicked a Sister
Mary Joseph's nodule and was later discovered to be a myoﬁbro-
blastic proliferation with an inclusion cyst.
A 53-year-old premenopausal female patient presented with a
huge, palpable, ﬁrm, nonmovable abdominal mass, which she had
had for 2 years. Her height was 153 cm and weight was 85.7 kg
(body mass index, 36.6 kg/m2). Progressively increasing abdominal
girth with an umbilical hard nodule had developed in the previous
year. Pelvic and physical examinations showed a huge palpable
pelvic tumor. The levels of the tumor markers carcinoembryonic
antigen (CEA), cancer antigen (CA)19-9, CA15-3, and CA125 were
1.1 ng/mL, 10.1 U/ mL, 23.1 U/ mL, and 65.6 U/ mL, respectively.
The pelvic ultrasound revealed a huge pelvic tumor measuring
20 cm  15 cm  10 cm with prominent blood ﬂow. A
4.5 cm  3.7 cm cystic umbilical mass was also present that had an* Corresponding author. Department of Pathology, Cathay General Hospital, No.
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blood ﬂow (Fig. 1). Under the suspicion of a Sister Mary Joseph's
nodule associated with an underlying malignancy, the patient was
scheduled for panendoscopy, colonoscopy, and computed tomog-
raphy (CT) scan. The panendoscopy and colonoscopy revealed su-
perﬁcial gastritis and mixed hemorrhoids, respectively. The CT scan
of the abdomen and pelvis demonstrated a uterine mass with an
isolated umbilical mass (Fig. 2). Therefore, the patient was sus-
pected of having a gynecologic-related malignancy with a Sister
Mary Joseph's nodule. After exploratory laparotomy, a 20-cm
uterine tumor and a 5-cm isolated umbilical tumor were found.
The frozen section examination of the uterine tumor revealed a
benign leiomyoma. The ﬁnal pathologic report of the umbilical
mass was myoﬁbroblastic proliferation with an inclusion cyst
(Fig. 3).
Total abdominal hysterectomy and bilateral salpingo-
oophorectomy were performed. The patient was discharged
without any complication on postoperative Day 5.
Throughout the world, cutaneous metastasis from malignant
neoplasms accounts for 0.7e9% of all patients with cancer [4]. The
rate of cutaneous metastases from different internal malignancies
accounts for 1.02% of Taiwanese patients with cancer [5]. Metastasis
to the umbilicus is rare and represents only 10% of all cutaneous
metastases [6,7]. Barrow [8] reports 667 cases of umbilical tumors
with 32% of the cases as endometriosis; 38%, as the primary tumor;
and 30%, as metastatic cancer. Sister Mary Joseph's nodule is a form
of metastasis to the umbilical region; most cases are metastatic
adenocarcinomawith a poor prognosis and a median survival of 10
months [9]. The most common origin of a Sister Mary Joseph's
nodule is from ovarian carcinoma in women and gastric carcinoma
in men [3,10].
Galvan [11] reports the most common origins of umbilical me-
tastases are gastric cancer (23.3%), colorectal cancer (14.9%), ovarian
cancer (16.7%), and uterine cancer (5.8%). In approximately 15e29%
of patients, the primary site is unknown [12]. The differential
diagnosis of umbilical nodules includes melanoma, squamous cell
carcinoma, myosarcoma, basal cell carcinoma, and non-neoplastic
diseases such as umbilical hernia, cutaneous endometriosis,
pyogenic granuloma, melanocytic nevus, keloids, papillomas,by Elsevier Taiwan LLC. All rights reserved.
Fig. 1. The abdominal ultrasound image demonstrates an isolated umbilical cystic
nodule (4.5 cm  3.7 cm) with an inner papillary solid growth (arrow) that lacks blood
ﬂow under Doppler ultrasound imaging.
Fig. 3. Umbilical tumor resection shows a cystic structure with mesothelial cell lining
(arrow) and proliferation of myoﬁbroblasts (short arrow) (hematoxylin and eosin,
200).
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bromas [13,14].
In this patient, blood vessels were absent in the umbilical mass.
This may indicate the benign characteristics of the mass. However,
even thoughtwo-dimensional (2D)and3DpowerDopplerultrasound
canbeused to discriminate betweenbenign andmalignant tumors by
determining tumor vascularity, their use adds little to a correct diag-
nosis of malignancy [15]. Surgical intervention with microscopic
examination remains the cornerstone of a correct diagnosis. In the
current case, the histology was proliferative myoﬁbroblasts.
Myoﬁbroblasts can originate from various cell types, but mostly
derive from locally recruited connective tissue ﬁbroblasts [16].
Myoﬁbroblasts have a crucial role in wound healing and patho-
logical organ remodeling; in the wound healing process, variousFig. 2. (A). Computed tomography (CT) imaging of the abdomen and pelvis shows an um
demonstrates a clear margin of the umbilical nodule and a huge uterine leiomyoma (star). (
component mimicking a Sister Mary Joseph's nodule (short arrow).cytokines and growth factors have been studied [17]. Under me-
chanical stress, ﬁbroblasts will differentiate into myoﬁbroblasts,
which leads to normal wound repair or pathological scarring [16].
In this patient, there was no trauma history of the umbilicus;
however, the huge uterine leiomyoma and obesity may have been
associated with mechanical stress. This may then have resulted in
ﬁbroblast differentiation into myoﬁbroblasts.
Sister Mary Joseph's nodule is a rare umbilical metastasis of
underlying malignancy, mostly from the gastrointestinal system or
gynecologic system. To the best of our knowledge, an umbilical
inclusion cyst mimicking a Sister Mary Joseph's nodule has not
previously been reported. We suggest that physicians should be
aware of this entity and should include it in the differential diag-
nosis of umbilical nodules.bilical nodule (arrow) that includes ﬂuid and a solid component inside. This image
B) The coronal section of the CT scan shows a superﬁcial nodule with a heterogeneous
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